Pharma Companies News

News

They hoped opioid settlement money would heal their community. It’s just not enough.

Payments to thousands of communities are welcome but are insufficient to deal with the scars of record overdoses.

4 min read22 Apr 2024
From:
Industry

Inside India’s plans for revamping clinical trials

India’s drug regulator has issued draft guidelines that would require pharmaceutical companies conducting clinical trials in the country to provide more detailed information on outcomes and adhere to strict reporting timelines.

2 min read17 Apr 2024
Industry

Generic Weight Loss Drugs Boosted by UK Approval for Biocon

Biocon Ltd. is pivoting to anti-obesity therapies as patents for the blockbuster medications start to expire, unleashing a wave of generic supply for the global weight-loss market that’s expected to touch $100 billion by 2030.

3 min read8 Apr 2024
Science

Biocon leads India’s push into blockbuster weight-loss drugs as patents for Saxenda, Wegovy and Ozempic set to expire

Biocon has won approval from the UK regulator for the first generic version of liraglutide injectible, which is losing patent protection in November.

1 min read8 Apr 2024
News

Ozempic Can’t Do It All—A Potential New Blockbuster Is a Reminder of That

Madrigal and other companies focused on treating fatty liver disease won’t get sidelined by obesity drugs.

3 min read18 Mar 2024
From:
Industry

Varda Hopes New Research Draws More Drugmakers to Space Factories

Varda Space Industries says it has a way to create better medicines: use microgravity.

3 min read12 Mar 2024
From:
Companies

Who was Ranjit Shahani: A titan in India’s pharmaceutical, business landscape. Know his contributions and more

Ranjit Shahani, was an influential figure in Indian pharma,and former President of OPPI. With a mechanical engineering degree from IIT Kanpur and an MBA from JBIMS Bombay, Shahani held notable positions at ICI and Roche Products before joining Novartis in 1997.

1 min read9 Mar 2024
News

Are Alternatives to Addictive Opioids on the Way?

Vertex’s clinical trials mark a step toward finding treatments for pain without addiction risks.

4 min read1 Mar 2024
From:
Industry

Inside India’s plans for revamping clinical trials

India’s drug regulator has issued draft guidelines that would require pharmaceutical companies conducting clinical trials in the country to provide more detailed information on outcomes and adhere to strict reporting timelines.

2 min read17 Apr 2024
Industry

Generic Weight Loss Drugs Boosted by UK Approval for Biocon

Biocon Ltd. is pivoting to anti-obesity therapies as patents for the blockbuster medications start to expire, unleashing a wave of generic supply for the global weight-loss market that’s expected to touch $100 billion by 2030.

3 min read8 Apr 2024
Load More

Popular Topics

Budget

The Union Budget contains details about the estimated receipts and the expenditure of the government for a particular fiscal year. The Budget is allotted for the upcoming fiscal year, which runs from 1st April to 31st March of the next year. Here is a quick guide on how the Union Budget is prepared

25 Articles

Plain Facts

Exciting, sharp and clear analysis of the trends that matter, through data and charts. Plain Facts is published every weekday, with coverage spanning across themes, including corporate strategy to inflation to unemployment and emerging sectors. Follow us on #MintPlainFacts across social media.

8 Articles
HomeMarketsPremiumFor youGet App